Keywords: Other Neurodegeneration, Brain
Motivation: To understand how abnormal copper metabolism affects the CSTC(Cortico-Striatal-Thalamo-Cortical) pathway in patients with neurological Wilson disease
Goal(s): To explore brain GABA level alterations in patients with neurologic Wilson disease compared to healthy controls.
Approach: Thirteen WD patients and eleven healthy controls underwent MRS on a 3.0T scanner, with GABA signals acquired from the left striatum and thalamus using MEGA-PRESS.
Results: For every one-unit decrease in GABA levels in the left striatum, the UWDRS decreased by 19.97. No changes were observed in the left thalamus.
Impact: These findings improve our understanding of WD and its severity. Future research should explore how copper chelation therapy affects CSTC pathways and whether restoring GABAergic function can help alleviate neurological deficits.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords